AG
ICPT

Advisor Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Advisor Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$165K Sell
1,333
-46
-3% -$4.12K ﹤0.01% 2546
2019
Q3 		$91K Buy
1,379
+993
+257% +$66.7K ﹤0.01% 2953
2019
Q2 		$30K Sell
386
-373
-49% -$33.4K ﹤0.01% 3711
2019
Q1 		$86K Buy
759
+20
+3% +$2.19K ﹤0.01% 2990
2018
Q4 		$74K Buy
739
+287
+63% +$29.7K ﹤0.01% 2895
2018
Q3 		$57K Sell
452
-13
-3% -$1.38K ﹤0.01% 3184
2018
Q2 		$39K Buy
465
+75
+19% +$5.49K ﹤0.01% 3291
2018
Q1 		$24K Buy
390
+255
+189% +$15.4K ﹤0.01% 3583
2017
Q4 		$8K Sell
135
-59
-30% -$3.72K ﹤0.01% 4236
2017
Q3 		$12K Sell
194
-155
-44% -$16.7K ﹤0.01% 3892
2017
Q2 		$43K Buy
349
+277
+385% +$32.1K ﹤0.01% 2947
2017
Q1 		$8K Buy
72
+71
+7,100% +$8.29K ﹤0.01% 3924
2016
Q4 		$0 Sell
1
-320
-100% -$38.1K ﹤0.01% 4661
2016
Q3 		$53K Sell
321
-5
-2% -$788 ﹤0.01% 2499
2016
Q2 		$46K Buy
+326
New +$47.5K ﹤0.01% 2478

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Advisor Group's ICPT Position: Q4 2019 in Review

Advisor Group reduced its Intercept Pharmaceuticals, Inc. (ICPT) stake by 3.3% in Q4 2019, selling an estimated $4.12K and leaving 1,333 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2546.

Advisor Group first reported a position in ICPT in Q2 2016 and has held it in 15 quarters since. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

  • Advisor Group held 1,333 shares of Intercept Pharmaceuticals, Inc. worth $165K as of Q4 2019.
  • Advisor Group sold 46 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $4.12K.
  • Intercept Pharmaceuticals, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2546 holding.
  • Advisor Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2016 and has held it in 15 quarters since.
  • 215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.